Abstract
Purpose
Lymph node (LN) metastasis is detected prior to distant metastasis in many types of cancer. Detecting early stage LN metastasis can improve treatment outcomes. However, there are few clinical imaging modalities capable of diagnosing metastatic LNs of clinical N0 status (i.e., before their volume increases) with high precision. Here, we report a new method for diagnosing metastatic LNs of clinical N0 status in a mouse model of LN metastasis.
Procedures
The method involved using intranodal lymphangiography with x-ray micro-computed tomography (micro-CT). Contrast agent was injected into an upstream LN to deliver it to a downstream LN, which was then removed and analyzed by micro-CT.
Results
We found that using an intranodal injection rate of 10–60 μl/min filled the lymphatic sinus of the downstream LN with contrast agent, although the accumulation of contrast agent in the upstream LN increased with a faster injection rate. Furthermore, breast cancer cells growing in the lymphatic sinus of the downstream LN (which was of clinical N0 status) impeded the flow of contrast agent from the upstream LN, resulting in areas deficient of contrast agent in the metastatic downstream LN. The formation of defect areas in the downstream LN manifested as a difference in position between the centroid of the entire LN area and the centroid of the region that filled with contrast agent.
Conclusion
The present study indicates that intranodal lymphangiography with micro-CT has the potential to be used as a new method for diagnosing metastatic LNs of clinical N0 status.
Similar content being viewed by others
References
Dieterich LC, Detmar M (2016) Tumor lymphangiogenesis and new drug development. Adv Drug Deliv Rev 99:148–160
Kodama T, Matsuki D, Tada A, Takeda K, Mori S (2016) New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network. Sci Rep 6:32506
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106
Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4–16
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready D, Mamounas EP, Costantino JP, Wolmark N, National Surgical Adjuvant Breast and Bowel Project (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888
Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, de Cicco C, Manfredi G, Fernández JR (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990
Karaman S, Detmar M (2014) Mechanisms of lymphatic metastasis. J Clin Invest 124:922–928
Shao L, Takeda K, Kato S, Mori S, Kodama T (2015) Communication between lymphatic and venous systems in mice. J Immunol Methods 424:100–105
Takeda K, Mori S, Kodama T (2017) Study of fluid dynamics reveals direct communications between lymphatic vessels and venous blood vessels at lymph nodes of mice. J Immunol Methods 445:1–9
Brown M, Assen FP, Leithner A, Abe J, Schachner H, Asfour G, Bago-Horvath Z, Stein JV, Uhrin P, Sixt M, Kerjaschki D (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359:1408–1411
Pereira ER, Kedrin D, Seano G, Gautier O, Meijer EFJ, Jones D, Chin SM, Kitahara S, Bouta EM, Chang J, Beech E, Jeong HS, Carroll MC, Taghian AG, Padera TP (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403–1407
Li L, Mori S, Kodama M, Sakamoto M, Takahashi S, Kodama T (2013) Enhanced sonographic imaging to diagnose lymph node metastasis: importance of blood vessel volume and density. Cancer Res 73:2082–2092
Miura Y, Mikada M, Ouchi T, Horie S, Takeda K, Yamaki T, Sakamoto M, Mori S, Kodama T (2016) Early diagnosis of lymph node metastasis: importance of intranodal pressures. Cancer Sci 107:224–232
Jeong HS, Jones D, Liao S, Wattson DA, Cui CH, Duda DG, Willett CG, Jain RK, Padera TP (2015) Investigation of the lack of angiogenesis in the formation of lymph node metastases. J Natl Cancer Inst 107
Mikada M, Sukhbaatar A, Miura Y, Horie S, Sakamoto M, Mori S, Kodama T (2017) Evaluation of the enhanced permeability and retention effect in the early stages of lymph node metastasis. Cancer Sci 108:846–852
Freeman NE (1949) Lymphangiography in the diagnosis of chylangioma and lymphedema; a preliminary report. Am J Med 6:390–391
Kinmonth J, Taylor G, Harper RK (1955) Lymphangiography. Br Med J 1:940–942
Yamashita K, Shimizu K (2009) Evaluation of sentinel lymph node metastasis alone guided by three-dimensional computed tomographic lymphography in video-assisted breast surgery. Surg Endosc 23:633–640
Nakagawa M, Morimoto M, Takechi H, Tadokoro Y, Tangoku A (2016) Preoperative diagnosis of sentinel lymph node (SLN) metastasis using 3D CT lymphography (CTLG). Breast Cancer 23:519–524
Itkin M, Nadolski GJ (2018) Modern techniques of lymphangiography and interventions: current status and future development. Cardiovasc Intervent Radiol 41:366–376
Li L, Mori S, Sakamoto M, Takahashi S, Kodama T (2013) Mouse model of lymph node metastasis via afferent lymphatic vessels for development of imaging modalities. PLoS One 8:e55797
Shao L, Mori S, Yagishita Y, Okuno T, Hatakeyama Y, Sato T, Kodama T (2013) Lymphatic mapping of mice with systemic lymphoproliferative disorder: usefulness as an inter-lymph node metastasis model of cancer. J Immunol Methods 389:69–78
Tanaka Y, Komori H, Mori S, Soga Y, Tsubaki T, Terada M, Miyazaki T, Fujino T, Nakamura S, Kanno H, Sawasaki T, Endo Y, Nose M (2010) Evaluating the role of rheumatoid factors for the development of rheumatoid arthritis in a mouse model with a newly established ELISA system. Tohoku J Exp Med 220:199–206
Kochi T, Imai Y, Takeda A, Watanabe Y, Mori S, Tachi M, Kodama T (2013) Characterization of the arterial anatomy of the murine hindlimb: functional role in the design and understanding of ischemia models. PLoS One 8:e84047
Tada A, Horie S, Mori S, Kodama T (2017) Therapeutic effect of cisplatin given with a lymphatic drug delivery system on false-negative metastatic lymph nodes. Cancer Sci 108:2115–2121
Cabral H, Makino J, Matsumoto Y, Mi P, Wu H, Nomoto T, Toh K, Yamada N, Higuchi Y, Konishi S, Kano MR, Nishihara H, Miura Y, Nishiyama N, Kataoka K (2015) Systemic targeting of lymph node metastasis through the blood vascular system by using size-controlled Nanocarriers. ACS Nano 9:4957–4967
Fujii H, Horie S, Takeda K, Mori S, Kodama T (2018) Optimal range of injection rates for a lymphatic drug delivery system. J Biophotonics 11:e201700401
Dori Y, Zviman MM, Itkin M (2014) Dynamic contrast-enhanced MR lymphangiography: feasibility study in swine. Radiology 273:410–416
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499
Fortuin AS, Bruggemann R, van der Linden J et al (2018) Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block. Wiley Interdiscip Rev Nanomed Nanobiotechnol 10:e1471
Harrell MI, Iritani BM, Ruddell A (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170:774–786
Alitalo A, Detmar M (2012) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31:4499–4508
Acknowledgements
The authors would like to thank T. Sato for technical assistance and the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support.
Funding
The study was supported by JSPS KAKENHI grant numbers 18H03544 (MS), 17K20077 (TK), and 17H00865 (TK).
Author information
Authors and Affiliations
Contributions
RI, SM, and TK designed the present study. RI, SM, and KT performed the experiments. RI, SM, and TK drafted the manuscript and prepared the figures. RI, MS, SM, and TK interpreted the data. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
PALN metastasis imaged by intranodal lymphangiography at day 14. Contrast agent was observed in the marginal, trabecular and medullary sinuses. (MP4 1724 kb)
PALN metastasis imaged by intranodal lymphangiography at day 21. Contrast agent was observed in the marginal, trabecular and medullary sinuses. (MP4 1756 kb)
PALN metastasis imaged by intranodal lymphangiography at day 28. Defect areas were observed. (MP4 1750 kb)
Rights and permissions
About this article
Cite this article
Iwamura, R., Sakamoto, M., Mori, S. et al. Imaging of the Mouse Lymphatic Sinus during Early Stage Lymph Node Metastasis Using Intranodal Lymphangiography with X-ray Micro-computed Tomography. Mol Imaging Biol 21, 825–834 (2019). https://doi.org/10.1007/s11307-018-01303-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-018-01303-4